Cogen J - Search Results

1

Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group. Cogen J, et al. Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9. Pediatr Pulmonol. 2015. PMID: 26061914 Free PMC article.

2

Pediatric Resident and Program Director Views on Climate Change and Health Curricula: A Multi-Institution Study.

Cogen JD, Perkins A, Mockler B, Barton KS, Schwartz A, Boos M, Radhakrishnan A, Rai P, Tandon P, Philipsborn R, Grow HM; APPD LEARN Climate Change Study Group. Cogen JD, et al. Acad Med. 2024 Jun 1;99(6):654-662. doi: 10.1097/ACM.0000000000005633. Epub 2024 Jan 12. Acad Med. 2024. PMID: 38232072

3

Cystic Fibrosis: The Dawn of a New Therapeutic Era.

Heltshe SL, Cogen J, Ramos KJ, Goss CH. Heltshe SL, et al. Among authors: cogen j. Am J Respir Crit Care Med. 2017 Apr 15;195(8):979-984. doi: 10.1164/rccm.201606-1250PP. Am J Respir Crit Care Med. 2017. PMID: 27710011 Free PMC article. No abstract available.

4

Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations.

Cogen JD, Oron AP, Gibson RL, Hoffman LR, Kronman MP, Ong T, Rosenfeld M. Cogen JD, et al. Pediatrics. 2017 Feb;139(2):e20162642. doi: 10.1542/peds.2016-2642. Pediatrics. 2017. PMID: 28126911 Free PMC article. Clinical Trial.

5

Pseudomonas aeruginosa eradication: Finally moving the needle?

Cogen J, Rosenfeld M. Cogen J, et al. J Cyst Fibros. 2017 May;16(3):309-310. doi: 10.1016/j.jcf.2017.04.001. Epub 2017 Apr 14. J Cyst Fibros. 2017. PMID: 28416146 Free article. No abstract available.

6

Effect of extending the time after bronchodilator administration on identifying bronchodilator responsiveness in a pediatric pulmonary clinic.

Cogen JD, DiBlasi RM, Gibson RL, Debley JS. Cogen JD, et al. Pediatr Pulmonol. 2017 Aug;52(8):984-989. doi: 10.1002/ppul.23752. Epub 2017 Jul 3. Pediatr Pulmonol. 2017. PMID: 28672068 Clinical Trial.

7

Treating Cystic Fibrosis Pulmonary Exacerbations: In the Hospital with a Physician or at Home under Your Own Supervision?

Cogen JD, Rosenfeld M. Cogen JD, et al. Ann Am Thorac Soc. 2018 Feb;15(2):169-170. doi: 10.1513/AnnalsATS.201711-891ED. Ann Am Thorac Soc. 2018. PMID: 29388818 No abstract available.

8

Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens.

Cogen JD, Onchiri F, Emerson J, Gibson RL, Hoffman LR, Nichols DP, Rosenfeld M. Cogen JD, et al. Ann Am Thorac Soc. 2018 Jun;15(6):702-709. doi: 10.1513/AnnalsATS.201801-012OC. Ann Am Thorac Soc. 2018. PMID: 29474110 Free PMC article.

9

Associating antimicrobial susceptibility testing with clinical outcomes in cystic fibrosis: More rigor and less frequency?

Szczesniak RD, Cogen JD, Rosenfeld M. Szczesniak RD, et al. J Cyst Fibros. 2019 Mar;18(2):159-160. doi: 10.1016/j.jcf.2019.02.008. Epub 2019 Feb 26. J Cyst Fibros. 2019. PMID: 30824378 Free PMC article. No abstract available.

10

Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.

Somayaji R, Russell R, Cogen JD, Goss CH, Nick SE, Saavedra MT, Taylor-Cousar JL, Nick JA, Nichols DP. Somayaji R, et al. Ann Am Thorac Soc. 2019 Jul;16(7):853-860. doi: 10.1513/AnnalsATS.201811-773OC. Ann Am Thorac Soc. 2019. PMID: 30840835 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters